|
業務類別
|
-- |
|
業務概覽
|
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. |
| 公司地址
| 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203 |
| 電話號碼
| +86 2161632588 |
| 傳真號碼
| +86 2161632570 |
| 公司網頁
| https://www.zailaboratory.com |
| 員工數量
| 1784 |
| Dr. Rafael G. Amado, M.D. |
President and Head of Global Research and Development |
美元 636.28K |
29/04/2025 |
| Mr. Frazor Titus Edmondson, III |
Chief Legal Officer |
美元 585.88K |
29/04/2025 |
| Dr. Samantha Du, PhD |
Chairperson of the Board and Chief Executive Officer |
美元 901.05K |
26/02/2026 |
| Mr. Joshua Smiley |
Chief Operating Officer and President |
美元 667.06K |
29/04/2025 |
| Dr. Yajing Chen, PhD |
Chief Financial Officer and Principal Accounting Officer |
美元 502.50K |
26/02/2026 |
|
|
| Mr. Leon Oliver Moulder, Jr |
Independent Director |
26/02/2026 |
| Mr. Peter Karl Wirth, J.D. |
Independent Director |
26/02/2026 |
| Mr. Scott William Morrison |
Independent Director |
26/02/2026 |
| Mr. Michel Pericles Vounatsos |
Independent Director |
26/02/2026 |
| Dr. John D. Diekman,PhD |
Lead Independent Director |
26/02/2026 |
| Dr. Samantha Du, PhD |
Chairperson of the Board and Chief Executive Officer |
26/02/2026 |
| Mr. William David Lis |
Independent Director |
26/02/2026 |
| Ms. Nisa Bernice Wing-Yu Leung, J.P. |
Independent Director |
26/02/2026 |
| Dr. Richard Brian Gaynor, M.D. |
Independent Director |
26/02/2026 |
|
|
|
|
